Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

New Frontiers of microRNA in Heart Failure: From Clinical Risk to Therapeutic Applications

Title: New Frontiers of microRNA in Heart Failure: From Clinical Risk to Therapeutic Applications
Authors: Fumarulo, Isabella; De Prisco, Andrea; Salerno, Elia Nunzio Maria; Vaccarella, Marcello; Garramone, Barbara; Burzotta, Francesco; Aspromonte, Nadia
Contributors: Fumarulo, Isabella; De Prisco, Andrea; Salerno, Elia Nunzio Maria; Ravenna, Salvatore Emanuele; Vaccarella, Marcello; Garramone, Barbara; Burzotta, Francesco; Aspromonte, Nadia
Publication Year: 2025
Collection: Università Cattolica del Sacro Cuore: PubliCatt
Subject Terms: biomarkers; diagnostics; heart failure; microRNA; pathogenesis; therapeutic perspective; Settore MEDS-07/B - Malattie dell'apparato cardiovascolare
Description: Heart failure (HF) is an increasingly prevalent disease with a major impact on morbidity and mortality worldwide. Continuous advancements in diagnostic and therapeutic strategies have significantly improved patient outcomes; however, precise biomarkers and novel therapeutic targets are still needed. In recent years, microRNAs (miRNAs) have emerged as promising biomarkers and potential therapeutic targets in HF. They consist of small, noncoding RNA molecules that regulate gene expression post-transcriptionally and are detectable in both tissues and blood, with disease-specific expression profiles that make them attractive candidates for non-invasive diagnosis, prognostic risk stratification, and even therapeutic interventions. In HF, miRNAs contribute to pathogenesis by modulating fibrosis, apoptosis, hypertrophy, and inflammation. The aim of this review is to analyze the role of circulating and tissue miRNAs in HF as biomarkers and as therapeutic targets. The future management of HF should include strategies to modulate miRNA expression in order to modify the disease trajectory and improve clinical outcomes.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/41010566; volume:14; issue:18; firstpage:N/A; lastpage:N/A; issueyear:2025; journal:JOURNAL OF CLINICAL MEDICINE; https://hdl.handle.net/10807/322737
DOI: 10.3390/jcm14186361
Availability: https://hdl.handle.net/10807/322737; https://doi.org/10.3390/jcm14186361
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.9009F3C1
Database: BASE